TrialLeukemia & lymphoma2014

Multicenter phase IV study of palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with non-Hodgkin lymphomas undergoing repeated cycles of moderately emetogenic chemotherapy.

Brian S Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.